Indus Capital Partners’s Legend Biotech LEGN Stock Holding History

Indus Capital Partners’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,064	Closed	-$485K	–	7
2023 Q1	$485K	Buy	+10,064	New	+$492K	0.74%	5
2022 Q1	–	Sell	-123,054	Closed	-$5.74M	–	35
2021 Q4	$5.74M	Buy	+123,054	New	+$6.24M	1.36%	21
2021 Q3	–	Sell	-94,678	Closed	-$3.89M	–	42
2021 Q2	$3.89M	Buy	+94,678	New	+$3.22M	0.66%	36
2020 Q3	–	Sell	-124,100	Closed	-$5.28M	–	46
2020 Q2	$5.28M	Buy	+124,100	New	+$4.85M	0.86%	30

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Indus Capital Partners's LEGN Position: Q2 2023 in Review

Indus Capital Partners sold out of Legend Biotech (LEGN) in Q2 2023, closing a stake of 10,064 shares — an estimated $485K sold.

Indus Capital Partners first reported a position in LEGN in Q2 2020 and held it in 4 quarters. The position peaked at $5.74M in Q4 2021. 194 funds tracked by Wall St. Rank hold LEGN as of Q2 2023.

Indus Capital Partners reported no remaining Legend Biotech position as of Q2 2023 after selling out during the quarter.
Indus Capital Partners sold 10,064 Legend Biotech shares in Q2 2023, an estimated $485K.
Indus Capital Partners first reported a position in Legend Biotech in Q2 2020 and held it in 4 quarters.
Indus Capital Partners's Legend Biotech position peaked at $5.74M in Q4 2021.
194 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2023.

Based on Indus Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.